Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Familial Periodic Paralyses
Show Display Options
RSS Create an RSS feed from your search for:
Familial Periodic Paralyses
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Hyper- and Hypokalemic Periodic Paralysis Study
Conditions: Hyperkalemic Periodic Paralysis;   Hypokalemic Periodic Paralysis
Interventions: Drug: Dichlorphenamide (double-blind);   Drug: Placebo (double-blind);   Drug: Dichlorphenamide (open-label)
2 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Conditions: Paralysis, Hyperkalemic Periodic;   Hypokalemic Periodic Paralysis;   Paramyotonia Congenita
Intervention: Drug: dichlorphenamide
3 Recruiting Lamotrigine as Treatment of Myotonia
Conditions: Dystrophia Myotonica Type 1;   Myotonia Congenita;   Paramyotonia Congenita;   Hyperkalemic Periodic Paralysis;   Potassium-Aggravated Myotonia
Interventions: Drug: Lamotrigine;   Drug: Placebo
4 Active, not recruiting Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis
Condition: Thyrotoxic Periodic Paralysis
Intervention: Other: No intervention involved

Indicates status has not been verified in more than two years